Can Postpartum Depression Be Prevented With Care
21 mars 2022 mis à jour par: Gulsen Eryilmaz, Ataturk University
Can Postpartum Depression Be Prevented With Care Provided To Primiparas Using Levine's Conservation Model: Single-Blind Randomized Controlled Experimental Study
This study was designed to eliminate postpartum insomnia and fatigue and reduce the risk of postpartum depression through the maintenance of structural, personal, and social integrity with holistic care under the guidance of Levine's conservation model for primiparous puerperal women who experience fatigue and are at risk of developing depression.
: A single-blind pretest-posttest randomized controlled study.
Women were called to the hospital on the 7th postpartum day and randomly assigned by a computer program to either the intervention group (n=56) or the control group (n=56).
Participants did not know which group they were in.
Aperçu de l'étude
Statut
Complété
Les conditions
Description détaillée
A nursing care program was prepared for the intervention group under the guidance of Levine's conservation model. This program was applied with 7 home visits between the 8th and 80th postpartum days. Face-to-face training and training booklets were provided in home visits. As of the fourth home visit, Pilates exercises were performed. The women in the control group received routine care. Pretest and posttest data were collected with a personal data sheet, visual analogue scale for fatigue, Postpartum Physical Symptom Severity Scale, Postpartum Sleep Quality Scale, Edinburgh Postpartum Depression Scale, and Postpartum Support Scale.
Sleep quality improved for the primiparous puerperal women of the intervention group. They had reduced postpartum fatigue and increased energy; maintained their structural, personal, and social integrity; and had decreased risk of developing postpartum depression with the holistic care provided (all p<0.001). A negative correlation was detected between the support subscale posttest total score from the Postpartum Support Scale and the posttest scores of the Edinburgh Postpartum Depression Scale for the women of the intervention group (r=-0.303; p<0.05)
Type d'étude
Interventionnel
Inscription (Réel)
112
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Erzurum, Turquie, 25240
- AtaturkU
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans à 35 ans (Adulte)
Accepte les volontaires sains
Oui
Sexes éligibles pour l'étude
Femelle
La description
Inclusion Criteria:
- primiparous;
- reading and understanding Turkish;
- normal term delivery;
- no risky situations during pregnancy or delivery;
- high score (≥65 points) from the Visual Analogue Scale to Evaluate Fatigue Severity (VAS-F),
- score of ≥12 points from the Edinburgh Postpartum Depression Scale (EPDS);
- episiotomy;
- hemoglobin value of at least 10.0 mg/dL;
- no current or past history of psychiatric illness.
Exclusion Criteria:
- inability to communicate
- unwillingness to participate in the research.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: The intervention group
To reduce postpartum depression among the primiparous puerperal women in the intervention group, and a nursing care program was implemented under the guidance of Levine's model.
This program was applied with 7 home visits between the 8th and 80th postpartum days.
Face-to-face training and training booklets were provided in home visits.
As of the fourth home visit, Pilates exercises were performed.
|
Face-to-face training and training booklets were provided in home visits.
As of the fourth home visit, Pilates exercises were performed.
|
|
Aucune intervention: The control group
In the control group women received routine postpartum care.
No interventions were conducted other than routine postpartum care.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Visual Analogue Scale to Evaluate Fatigue Severity Scores
Délai: 1- 7th day after giving birth, Time Frame: 2- postpartum 12th week
|
The highest score that can be obtained for the fatigue subdimension is 130 and the lowest score is 0. The highest score that can be obtained from the energy subdimension is 50 and the lowest score is 0. Higher scores on items measuring fatigue and lower scores on items measuring energy indicate that the severity of fatigue is high.
|
1- 7th day after giving birth, Time Frame: 2- postpartum 12th week
|
|
Edinburgh Postpartum Depression Scale Scores
Délai: 1- 7th day after giving birth, Time Frame: 2- postpartum 12th week
|
The highest score that can be obtained from the scale is 30.
A score of 12 or more indicates that the individual is at risk of depression.
|
1- 7th day after giving birth, Time Frame: 2- postpartum 12th week
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
The Postpartum Support Scale Scores
Délai: 1- postpartum 8th day Time Frame: 2- Postpartum 12th week
|
The lowest score that can be obtained from the scale is 0 and the highest score is 238.
The higher the total score, the greater the need for support and the greater the support that needs to be received.
|
1- postpartum 8th day Time Frame: 2- Postpartum 12th week
|
|
the Postpartum Sleep Quality Scale Scores
Délai: 1- postpartum 8th day Time Frame: 2- Postpartum 12th week
|
The lowest and highest possible scores are respectively 0 and 56.
Higher scores indicate lower sleep quality.
|
1- postpartum 8th day Time Frame: 2- Postpartum 12th week
|
|
The Postpartum Physical Symptom Severity Scale Scores
Délai: 1- postpartum 8th day Time Frame: 2- Postpartum 12th week
|
Total possible scores range between 0 and 54.
Higher scores obtained from this scale indicate higher severity of postpartum physical symptoms.
|
1- postpartum 8th day Time Frame: 2- Postpartum 12th week
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
1 juillet 2019
Achèvement primaire (Réel)
1 avril 2020
Achèvement de l'étude (Réel)
9 mars 2021
Dates d'inscription aux études
Première soumission
9 mars 2022
Première soumission répondant aux critères de contrôle qualité
21 mars 2022
Première publication (Réel)
24 mars 2022
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
24 mars 2022
Dernière mise à jour soumise répondant aux critères de contrôle qualité
21 mars 2022
Dernière vérification
1 mars 2022
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- AtaturkU-GulsenEryilmaz-001
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Description du régime IPD
There is not a plan to make IPD available
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .